Skip to main content
Top
Published in: Clinical and Experimental Nephrology 10/2019

01-10-2019 | Glomerulonephritis | Correction

Correction to: Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center

Authors: Marie Nakano, Kazunori Karasawa, Takahito Moriyama, Keiko Uchida, Kosaku Nitta

Published in: Clinical and Experimental Nephrology | Issue 10/2019

Login to get access

Excerpt

In the Original publication, the authors found few errors in the text. The corrections are given below:
1.
The “Complement (CP)-mediated MPGN” should read as “Alternative pathway (AP)-mediated MPGN” throughout the article.
 
2.
Under the Conclusion and Discussion section, the sentence “These results suggested no significant differences in complement activation of the solid phase in local glomeruli and therefore no equivalence in renal prognosis” should read as “These results suggested no significant differences in complement activation of the solid phase in local glomeruli and therefore equivalent in renal prognosis”.
 
3.
Under the Statistical analysis, the text “Categorical variables were expressed as the mean ± standard deviation unless specified otherwise and were compared using the unpaired t test or Mann–Whitney U test” should read as “Categorical variables were expressed as the number and percentage and were compared using Fisher’s exact test” to analyze differences in laboratory and histological data.
 
Metadata
Title
Correction to: Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center
Authors
Marie Nakano
Kazunori Karasawa
Takahito Moriyama
Keiko Uchida
Kosaku Nitta
Publication date
01-10-2019
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 10/2019
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-019-01778-7

Other articles of this Issue 10/2019

Clinical and Experimental Nephrology 10/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.